111Category: | Intermediates/Pharmaceutical intermediates |
|
|
CAS NO: | 161796-78-7 | ||
EC NO: | |||
Molecular Formula: | C34H36MgN6O6S2 | ||
Molecular Weight: | 713.1212 | ||
Specification: | |||
InChI: | InChI=1/2C17H18N3O3S.Mg/c2*1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17;/h2*5-8H,9H2,1-4H3;/q2*-1;+2/rC34H36MgN6O6S2/c1-19-15-36-27(21(3)31(19)46-7)17-48(42)33-38-25-13-23(44-5)9-11-29(25)40(33)35-41-30-12-10-24(45-6)14-26(30)39-34(41)49(43)18-28-22(4)32(47-8)20(2)16-37-28/h9-16H,17-18H2,1-8H3 | ||
Synonyms: | 1H-benzimidazole, 5-Methoxy-2-[[(4-Methoxy-3,5-dimethyl-2-PYRIDINYL)methyl]sulfinyl]-, sodium salt;Esomeprazoleandsalts;5-Methoxy-2-((S)-((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl-1H-benzimidazole sodium salt;sodium 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}benzimidazol-1-ide;sodium 5-methoxy-2-{(S)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-2,3-dihydrobenzimidazol-1-ide;bis[5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]benzimidazol-1-yl]magnesium;Esomeprazole Na; | ||
Molecular Structure: |